Cellular engagement of the SARS-CoV-2 macrodomain by GS-441524 and enhanced in vitro inhibition by its diphosphorylated metabolite.

Publication date: Jun 18, 2026

Coronavirus macrodomains (Mac1) counter host immunity by removing ADP-ribose. GS-441524, the parent nucleoside of remdesivir, inhibits SARS-CoV-2 Mac1, but its active metabolite and cellular engagement were undefined. GS-441524 selectively inhibits SARS-CoV-2 Mac1 over human MacroD2, engages Mac1 in cells but not MERS-CoV Mac1, with its diphosphate metabolite being most potent.

Open Access PDF

Concepts Keywords
Coronavirus Cellular
Enhanced Coronavirus
Host Counter
Macrod2 Cov
Diphosphorylated
Engagement
Enhanced
Gs
Inhibition
Inhibits
Mac1
Macrodomain
Macrodomains
Metabolite
Sars

Semantics

Type Source Name
disease MESH viral infection
disease MESH rubella
disease MESH hepatitis
disease MESH dis
disease MESH COVID 19 pandemic
drug DRUGBANK Adenosine-5-Diphosphoribose
drug DRUGBANK Flunarizine
drug DRUGBANK Coenzyme M
drug DRUGBANK Dimethyl sulfoxide
disease MESH infection
drug DRUGBANK Phosphate ion
drug DRUGBANK Adenosine
drug DRUGBANK Adenine
drug DRUGBANK Water
drug DRUGBANK Proline
disease MESH MES
drug DRUGBANK Sodium lauryl sulfate
disease MESH SDS
drug DRUGBANK Esomeprazole
disease MESH Image
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Histidine
drug DRUGBANK Cysteamine
disease MESH ham
disease MESH included
drug DRUGBANK Ilex paraguariensis leaf
pathway KEGG Viral replication
disease MESH infectious diseases
disease MESH severe acute respiratory syndrome
disease MESH coronavirus infection
drug DRUGBANK L-Isoleucine
drug DRUGBANK Troleandomycin
pathway REACTOME Metabolism
drug DRUGBANK Diethylstilbestrol
disease MESH Des

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *